Marie Jones - Mar 9, 2023 Form 3 Insider Report for Silk Road Medical Inc (SILK)

Role
CAO and VP, Finance
Signature
/s/ Jones, Marie L
Stock symbol
SILK
Transactions as of
Mar 9, 2023
Transactions value $
$0
Form type
3
Date filed
3/20/2023, 06:01 AM
Next filing
Jul 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SILK Common Stock 45.5K Mar 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 6.5K $55.30 Direct F1
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 11.9K $36.55 Direct F2
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 9.23K $30.93 Direct F3
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 10K $6.11 Direct F4
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 8.49K $6.11 Direct F4
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 65.1K $6.11 Direct F4
holding SILK Option (right to buy) Mar 9, 2023 Common Stock 6.55K $6.11 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth of the shares subject to the option vested on April 1, 2021 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 One forty-eighth of the shares subject to the option vested on April 1, 2022 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F3 One forty-eighth of the shares subject to the option vested on April 1, 2020 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F4 All of the shares subject to the option are fully vested and exercisable as of the date hereof.